欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球肝细胞癌治疗市场预测流行病学管道分析(2022-2027年)

Global Hepatocellular Carcinoma Treatment Market Forecast - Epidemiology Pipeline Analysis 2022-2027

加工时间:2023-04-28 信息来源:EMIS 索取原文[189 页]
关键词:肝细胞癌 (HCC) ;原发性肝癌类型;慢性肝病患者;乙型肝炎;丙型肝炎;肝硬化
摘 要:

Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma constitutes more than 90% of the primary tumor of the liver. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection, accounting for ~50% of cases.


目 录:

CHAPTER – 1: HEPATOCELLULAR CARCINOMA OVERVIEW

CHAPTER – 2: HEPATOCELLULAR CARCINOMA EPIDEMIOLOGY & OVERVIEW

CHAPTER - 3: HEPATOCELLULAR CARCINOMA MARKET SIZE & OVERVIEW

CHAPTER – 4: HEPATOCELLULAR CARCINOMA MARKETED DRUGS OVERVIEW

CHAPTER – 5: HEPATOCELLULAR CARCINOMA PIPELINE DRUGS OVERVIEW


© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服